Jundishapur Journal of Microbiology

Published by: Kowsar

Antigenicity Identification of a Novel Recombinant Multi-Epitope Antigen Based on FlaA and UreB Antigens of Helicobacter pylori

Zeinab Hamzehloo ORCID 1 , Ghasem Mosayebi ORCID 2 , Behzad Khansarinejad ORCID 2 , Mina Zolfaghari ORCID 2 and Hamid Abtahi ORCID 2 , *
Authors Information
1 Department of Biotechnology, School of Medicine, Arak University of Medical Sciences, Arak, Iran
2 Molecular and Medical Research Center, Arak University of Medical Sciences, Arak, Iran
Article information
  • Jundishapur Journal of Microbiology: May 31, 2019, 12 (5); e66502
  • Published Online: May 4, 2019
  • Article Type: Research Article
  • Received: January 20, 2018
  • Revised: March 10, 2019
  • Accepted: March 14, 2019
  • DOI: 10.5812/jjm.66502

To Cite: Hamzehloo Z , Mosayebi G, Khansarinejad B, Zolfaghari M , Abtahi H. Antigenicity Identification of a Novel Recombinant Multi-Epitope Antigen Based on FlaA and UreB Antigens of Helicobacter pylori, Jundishapur J Microbiol. 2019 ; 12(5):e66502. doi: 10.5812/jjm.66502.

Copyright © 2019, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
  • 1. Linz B, Balloux F, Moodley Y, Manica A, Liu H, Roumagnac P, et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature. 2007;445(7130):915-8. doi: 10.1038/nature05562. [PubMed: 17287725]. [PubMed Central: PMC1847463].
  • 2. McMahon BJ, Bruce MG, Koch A, Goodman KJ, Tsukanov V, Mulvad G, et al. The diagnosis and treatment of Helicobacter pylori infection in Arctic regions with a high prevalence of infection: Expert Commentary. Epidemiol Infect. 2016;144(2):225-33. doi: 10.1017/S0950268815001181. [PubMed: 26094936]. [PubMed Central: PMC4697284].
  • 3. Frydman GH, Davis N, Beck PL, Fox JG. Helicobacter pylori eradication in patients with immune thrombocytopenic purpura: A review and the role of biogeography. Helicobacter. 2015;20(4):239-51. doi: 10.1111/hel.12200. [PubMed: 25728540]. [PubMed Central: PMC4506733].
  • 4. Farjadi V, Abtahi H, Zolfaghari MR, Soufian S, Hasanzadeh L. Expression, purification and evaluation of antigenicity of CagA antigenic fragment of Helicobacter pylori. Jundishapur J Microbiol. 2013;6(9). e7367. doi: 10.5812/jjm.7367.
  • 5. Perrais M, Rousseaux C, Ducourouble MP, Courcol R, Vincent P, Jonckheere N, et al. Helicobacter pylori urease and flagellin alter mucin gene expression in human gastric cancer cells. Gastric Cancer. 2014;17(2):235-46. doi: 10.1007/s10120-013-0267-5. [PubMed: 23703470].
  • 6. Zhang H, Liu M, Li Y, Zhao Y, He H, Yang G, et al. Oral immunogenicity and protective efficacy in mice of a carrot-derived vaccine candidate expressing UreB subunit against Helicobacter pylori. Protein Expr Purif. 2010;69(2):127-31. doi: 10.1016/j.pep.2009.07.016. [PubMed: 19651219].
  • 7. Xing Y, Liu W, Li X, Guo L, Lv X, Xi T. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori. Biochem Biophys Res Commun. 2015;462(3):269-74. doi: 10.1016/j.bbrc.2015.04.130. [PubMed: 25957472].
  • 8. Zhou WY, Shi Y, Wu C, Zhang WJ, Mao XH, Guo G, et al. Therapeutic efficacy of a multi-epitope vaccine against Helicobacter pylori infection in BALB/c mice model. Vaccine. 2009;27(36):5013-9. doi: 10.1016/j.vaccine.2009.05.009. [PubMed: 19446591].
  • 9. Zavala-Spinetti L, Breslin MB, Correa H, Begue RE. Development and evaluation of a DNA vaccine based on Helicobacter pylori urease B: Failure to prevent experimental infection in the mouse model. Helicobacter. 2006;11(6):517-22. doi: 10.1111/j.1523-5378.2006.00453.x. [PubMed: 17083372].
  • 10. Corthesy B, Boris S, Isler P, Grangette C, Mercenier A. Oral immunization of mice with lactic acid bacteria producing Helicobacter pylori urease B subunit partially protects against challenge with Helicobacter felis. J Infect Dis. 2005;192(8):1441-9. doi: 10.1086/444425. [PubMed: 16170763].
  • 11. Liu KY, Shi Y, Luo P, Yu S, Chen L, Zhao Z, et al. Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model. Vaccine. 2011;29(38):6679-85. doi: 10.1016/j.vaccine.2011.06.099. [PubMed: 21745524].
  • 12. Andersen LP, Espersen F. Immunoglobulin G antibodies to Helicobacter pylori in patients with dyspeptic symptoms investigated by the western immunoblot technique. J Clin Microbiol. 1992;30(7):1743-51. [PubMed: 1629330]. [PubMed Central: PMC265374].
  • 13. Simor AE, Lin E, Saibil F, Cohen L, Louie M, Pearen S, et al. Evaluation of enzyme immunoassay for detection of salivary antibody to Helicobacter pylori. J Clin Microbiol. 1996;34(3):550-3. [PubMed: 8904412]. [PubMed Central: PMC228844].
  • 14. Manes G, Zanetti MV, Piccirillo MM, Lombardi G, Balzano A, Pieramico O. Accuracy of a new monoclonal stool antigen test in post-eradication assessment of Helicobacter pylori infection: Comparison with the polyclonal stool antigen test and urea breath test. Dig Liver Dis. 2005;37(10):751-5. doi: 10.1016/j.dld.2005.03.012. [PubMed: 16023902].
  • 15. Pelerito A, Oleastro M, Lopes AI, Ramalho P, Cabral J, Monteiro L. Evaluation of rapid test Assure Helicobacter pylori for diagnosis of H. pylori in pediatric population. J Microbiol Methods. 2006;66(2):331-5. doi: 10.1016/j.mimet.2005.12.013. [PubMed: 16516992].
  • 16. Stingl K, Altendorf K, Bakker EP. Acid survival of Helicobacter pylori: How does urease activity trigger cytoplasmic pH homeostasis? Trends Microbiol. 2002;10(2):70-4. doi: 10.1016/S0966-842X(01)02287-9. [PubMed: 11827807].
  • 17. Weeks DL, Eskandari S, Scott DR, Sachs G. A H+-gated urea channel: The link between Helicobacter pylori urease and gastric colonization. Science. 2000;287(5452):482-5. doi: 10.1126/science.287.5452.482. [PubMed: 10642549].
  • 18. Begue RE, Sadowska-Krowicka H. Protective efficacy of recombinant urease B and aluminum hydroxide against Helicobacter pylori infection in a mouse model. FEMS Immunol Med Microbiol. 2010;60(2):142-6. doi: 10.1111/j.1574-695X.2010.00726.x. [PubMed: 20731722]. [PubMed Central: PMC2970735].
  • 19. Yan J, Wang Y, Shao SH, Mao YF, Li HW, Luo YH. Construction of prokaryotic expression system of ltB-ureB fusion gene and identification of the recombinant protein immunity and adjuvanticity. World J Gastroenterol. 2004;10(18):2675-9. doi: 10.3748/wjg.v10.i18.2675. [PubMed: 15309718]. [PubMed Central: PMC4572192].
  • 20. Raoufi E, Akrami H, Khansarinejad B, Abtahi H. Expression and antigenic evaluation of Helicobacter pylori UreB fragment. Jundishapur J Microbiol. 2017;10(5). e41645. doi: 10.5812/jjm.41645.
  • 21. Kostrzynska M, Betts JD, Austin JW, Trust TJ. Identification, characterization, and spatial localization of two flagellin species in Helicobacter pylori flagella. J Bacteriol. 1991;173(3):937-46. doi: 10.1128/jb.173.3.937-946.1991. [PubMed: 1704004]. [PubMed Central: PMC207209].
  • 22. Wu CC, Chou PY, Hu CT, Liu ZC, Lin CY, Tseng YH, et al. Clinical relevance of the vacA, iceA, cagA, and flaA genes of Helicobacter pylori strains isolated in Eastern Taiwan. J Clin Microbiol. 2005;43(6):2913-5. doi: 10.1128/JCM.43.6.2913-2915.2005. [PubMed: 15956417]. [PubMed Central: PMC1151873].
  • 23. Zarei M, Mosayebi G, Khansarinejad B, Abtahi H. Antigenic and immunogenic evaluation of Helicobacter pylori FlaA epitopes. Iran J Basic Med Sci. 2017;20(8):920-6. doi: 10.22038/IJBMS.2017.9115. [PubMed: 29085584]. [PubMed Central: PMC5651478].
  • 24. Tong JC, Tan TW, Ranganathan S. Methods and protocols for prediction of immunogenic epitopes. Brief Bioinform. 2007;8(2):96-108. doi: 10.1093/bib/bbl038. [PubMed: 17077136].
  • 25. Sambrook J, Russel D. Molecular cloning: A laboratory manual. 3rd ed. New york: Cold Spring Harbor Laboratory Press; 2001.
  • 26. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977;74(12):5463-7. doi: 10.1073/pnas.74.12.5463. [PubMed: 271968]. [PubMed Central: PMC431765].
  • 27. Ghaffari-Nazari H, Tavakkol-Afshari J, Jaafari MR, Tahaghoghi-Hajghorbani S, Masoumi E, Jalali SA. Improving multi-epitope long peptide vaccine potency by using a strategy that enhances CD4+ T help in BALB/c Mice. PLoS One. 2015;10(11). e0142563. doi: 10.1371/journal.pone.0142563. [PubMed: 26556756]. [PubMed Central: PMC4640540].
  • 28. de Oliveira LM, Morale MG, Chaves AA, Cavalher AM, Lopes AS, Diniz Mde O, et al. Design, immune responses and anti-tumor potential of an HPV16 E6E7 multi-epitope vaccine. PLoS One. 2015;10(9). e0138686. doi: 10.1371/journal.pone.0138686. [PubMed: 26390407]. [PubMed Central: PMC4577214].
  • 29. Cao A, Liu Y, Wang J, Li X, Wang S, Zhao Q, et al. Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice. Vaccine. 2015;33(48):6757-62. doi: 10.1016/j.vaccine.2015.10.077. [PubMed: 26518401].
  • 30. Chowdhury MY, Seo SK, Moon HJ, Talactac MR, Kim JH, Park ME, et al. Heterosubtypic protective immunity against widely divergent influenza subtypes induced by fusion protein 4sM2 in BALB/c mice. Virol J. 2014;11:21. doi: 10.1186/1743-422X-11-21. [PubMed: 24502341]. [PubMed Central: PMC3923897].
  • 31. Paul S, Piontkivska H. Frequent associations between CTL and T-Helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designs. BMC Microbiol. 2010;10:212. doi: 10.1186/1471-2180-10-212. [PubMed: 20696039]. [PubMed Central: PMC2924856].
  • 32. Camussone C, Gonzalez V, Belluzo MS, Pujato N, Ribone ME, Lagier CM, et al. Comparison of recombinant Trypanosoma cruzi peptide mixtures versus multiepitope chimeric proteins as sensitizing antigens for immunodiagnosis. Clin Vaccine Immunol. 2009;16(6):899-905. doi: 10.1128/CVI.00005-09. [PubMed: 19339486]. [PubMed Central: PMC2691048].
  • 33. Hajissa K, Zakaria R, Suppian R, Mohamed Z. Design and evaluation of a recombinant multi-epitope antigen for serodiagnosis of Toxoplasma gondii infection in humans. Parasit Vectors. 2015;8:315. doi: 10.1186/s13071-015-0932-0. [PubMed: 26062975]. [PubMed Central: PMC4465724].
  • 34. Dipti CA, Jain SK, Navin K. A novel recombinant multiepitope protein as a hepatitis C diagnostic intermediate of high sensitivity and specificity. Protein Expr Purif. 2006;47(1):319-28. doi: 10.1016/j.pep.2005.12.012. [PubMed: 16504539].
  • 35. Cheng Z, Zhao JW, Sun ZQ, Song YZ, Sun QW, Zhang XY, et al. Evaluation of a novel fusion protein antigen for rapid serodiagnosis of tuberculosis. J Clin Lab Anal. 2011;25(5):344-9. doi: 10.1002/jcla.20483. [PubMed: 21919069].
  • 36. Cremonini F, Gabrielli M, Gasbarrini G, Pola P, Gasbarrini A. The relationship between chronic H. pylori infection, CagA seropositivity and stroke: Meta-analysis. Atherosclerosis. 2004;173(2):253-9. doi: 10.1016/j.atherosclerosis.2003.12.012. [PubMed: 15064099].
  • 37. Schumann C, Triantafilou K, Rasche FM, Moricke A, Vogt K, Triantafilou M, et al. Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease. Int J Med Microbiol. 2006;296(4-5):223-8. doi: 10.1016/j.ijmm.2006.02.009. [PubMed: 16600680].
  • 38. Jiang Z, Tao XH, Huang AL, Wang PL. A study of recombinant protective H.pylori antigens. World J Gastroenterol. 2002;8(2):308-11. doi: 10.3748/wjg.v8.i2.308. [PubMed: 11925614]. [PubMed Central: PMC4658373].
  • 39. Michetti P, Kreiss C, Kotloff KL, Porta N, Blanco JL, Bachmann D, et al. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology. 1999;116(4):804-12. doi: 10.1016/S0016-5085(99)70063-6. [PubMed: 10092302].
  • 40. Yan J, Mao YF, Shao ZX. Frequencies of the expression of main protein antigens from Helicobacter pylori isolates and production of specific serum antibodies in infected patients. World J Gastroenterol. 2005;11(3):421-5. doi: 10.3748/wjg.v11.i3.421. [PubMed: 15637759]. [PubMed Central: PMC4205353].
  • 41. Mao YF, Yan J. Construction of prokaryotic expression system of ureB gene from a clinical Helicobacter pylori strain and identification of the recombinant protein immunity. World J Gastroenterol. 2004;10(7):977-84. doi: 10.3748/wjg.v10.i7.977. [PubMed: 15052678]. [PubMed Central: PMC4717116].
  • 42. Blanchard T NJ. Helicobacter pylori vaccine. Helicobacter pylori in the 21st century. Wallingford, Oxforshire, UK: CABI; 2010.
  • 43. Ferrero RL, Thiberge JM, Kansau I, Wuscher N, Huerre M, Labigne A. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci U S A. 1995;92(14):6499-503. doi: 10.1073/pnas.92.14.6499. [PubMed: 7604021]. [PubMed Central: PMC41545].
  • 44. Flach CF, Svensson N, Blomquist M, Ekman A, Raghavan S, Holmgren J. A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori. Vaccine. 2011;29(6):1235-41. doi: 10.1016/j.vaccine.2010.11.088. [PubMed: 21147129].
  • 45. Nystrom J, Svennerholm AM. Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses. Vaccine. 2007;25(14):2591-8. doi: 10.1016/j.vaccine.2006.12.026. [PubMed: 17239498].
  • 46. Arai R, Ueda H, Kitayama A, Kamiya N, Nagamune T. Design of the linkers which effectively separate domains of a bifunctional fusion protein. Protein Eng. 2001;14(8):529-32. doi: 10.1093/protein/14.8.529. [PubMed: 11579220].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments